The cost of stroke in private hospitals in Brazil: a one-year prospective study.
Luana Gabriela Dalla Rosa VieiraJuliana SafanelliTainá de AraujoHelen Aparecida SchuchMaria Helena Ribeiro KuhlhoffVivian NagelAdriana Bastos ConfortoGisele Sampaio SilvaSuleimy Cristina MazinNorberto Luiz CabralPublished in: Arquivos de neuro-psiquiatria (2019)
Stroke is a costly disease. In the private sector, the costs of cerebral reperfusion for IS treatment were three-to-ten times higher than for usual treatments. Therefore, cost-effectiveness studies are urgently needed in low- and middle-income countries.